SEC Form 4 · accession 0001753159-26-000014
Guardant Health, Inc. · GH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
AmirAli Talasaz
Officer — Co-Chief Executive Officer · Director
Period of report
Jun 26, 2026
Accepted (ET)
Jun 30, 2026 · 5:13 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001576280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 26, 2026 | M | 111,804 | $4.18 | A | 1,998,308 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common StockF1 | Jun 26, 2026 | S | 64,037 | $150.4886 | D | 1,934,271 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common StockF2 | Jun 26, 2026 | S | 52,935 | $151.1595 | D | 1,881,336 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common Stock | Jun 29, 2026 | M | 143,028 | $4.18 | A | 2,024,364 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common StockF1 | Jun 29, 2026 | S | 25,812 | $150.5282 | D | 1,998,552 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common StockF3 | Jun 29, 2026 | S | 70,513 | $151.4659 | D | 1,928,039 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common StockF4 | Jun 29, 2026 | S | 46,663 | $152.2045 | D | 1,881,376 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common Stock | Jun 29, 2026 | S | 40 | $153.00 | D | 1,881,336 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $4.18 | Jun 26, 2026 | M | 111,804 | D | — | Jul 14, 2027 | Common Stock | 111,804 | 172,025 | D |
| Stock Option (Right to Buy)F5 | $4.18 | Jun 29, 2026 | M | 143,028 | D | — | Jul 14, 2027 | Common Stock | 143,028 | 28,997 | D |
Explanation of responses
- F1Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.79. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $152.00 to $152.68. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F5The stock option vested in equal monthly installments over 48 months commencing on April 23, 2017.